QI-Core Implementation Guide
6.0.0 - STU6 United States of America flag

This page is part of the Quality Improvement Core Framework (v6.0.0: STU6 (v6.0.0)) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Medication: Medication example

Generated Narrative: Medication

Resource Medication "example"

Profile: QICore Medication

code: alemtuzumab 10 MG/ML [Lemtrada] (RxNorm#1594660)

manufacturer:

identifier: United States National Provider Identifier/8635143786 (use: TEMP)

active: true

name: Genzyme

telecom: https://www.sanofigenzyme.com/

address: Cambridge MA USA (WORK)

form: Conventional release solution for injection (dose form) (SNOMED CT#385219001)

Ingredients

-Item[x]Strength
*Alemtuzumab (substance) (SNOMED CT#129472003)12 mg (Details: UCUM code mg = 'mg')/1.2 mL (Details: UCUM code mL = 'mL')

Batches

-LotNumberExpirationDate
*94947882017-05-22

Generated Narrative: Organization #org6

identifier: United States National Provider Identifier/8635143786 (use: TEMP)

active: true

name: Genzyme

telecom: https://www.sanofigenzyme.com/

address: Cambridge MA USA (WORK)